Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.30538 | 11 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.29658 | 12 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.30047 | 12 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.26969 | 13 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.26333 | 12 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.33496 | 11 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.29271 | 11 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.28031 | 12 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.27751 | 12 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.28413 | 12 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.28058 | 12 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.28441 | 12 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.29297 | 12 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.28727 | 12 |